Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus

PURPOSE: Sodium-glucose cotransporter 2 inhibitor (SGLT2i) regulation, developed as treatment for patients with type 2 diabetes, can be imaged with the glucose analogue alpha-methyl-4-deoxy-4-[(18)F]fluoro-d-glucopyranoside (Me4FDG), a positron emission tomography (PET) tracer with a high affinity f...

Descripción completa

Detalles Bibliográficos
Autores principales: Geist, Barbara Katharina, Brath, Helmut, Zisser, Lucia, Yu, Josef, Fueger, Barbara, Nics, Lukas, Patronas, Eva Maria, Kautzky-Willer, Alexandra, Hacker, Marcus, Rasul, Sazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382381/
https://www.ncbi.nlm.nih.gov/pubmed/37195445
http://dx.doi.org/10.1007/s00259-023-06256-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382381/
https://www.ncbi.nlm.nih.gov/pubmed/37195445
http://dx.doi.org/10.1007/s00259-023-06256-7

Ejemplares similares